Skip to menu Skip to content Skip to footer

2003

Conference Publication

Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression

Clouston, A. D., Jonsson, J. R., Letizia, B., Richardson, M. M., Vanags, D. M., Walsh, M., Demetris, A. J. and Powell, E. E. (2003). Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression. 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons.

Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression

2003

Journal Article

Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor-α and cytochrome P450 2E1

Gochee, P. A., Jonsson, J. R., Clouston, A. D., Pandeya, N., Purdie, D. M. and Powell, E. E. (2003). Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor-α and cytochrome P450 2E1. Journal of Gastroenterology And Hepatology, 18 (4), 386-392. doi: 10.1046/j.1440-1746.2003.02984.x

Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor-α and cytochrome P450 2E1

2003

Conference Publication

Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for success

Hickman, I. J., Jonsson, J. R., Prins, J. B., Ash, S., Purdie, D. M., Clouston, A. D. and Powell, E. E. (2003). Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for success. 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/hep.1840380507

Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for success

2003

Journal Article

Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese

Dixon, JB, Bhathal, PS, Jonsson, JR, Dixon, AF, Powell, EE and O'Brien, PE (2003). Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. Journal of Hepatology, 39 (6), 967-971. doi: 10.1016/S0168-8278(03)00459-8

Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese

2003

Journal Article

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001

Law M.G., Dore G.J., Bath N., Thompson S., Crofts N., Dolan K., Giles W., Gow P., Kaldor J., Loveday S., Powell E., Spencer J. and Wodak A. (2003). Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. International Journal of Epidemiology, 32 (5), 717-724. doi: 10.1093/ije/dyg101

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001

2002

Journal Article

Lymphocyte apoptosis and cell replacement in human liver allografts

Clouston, Andrew D., Jonsson, Julie R., Balderson, Glenda A., Fawcett, Jonathon, Lynch, Stephen V., Kelso, Anne and Powell, Elizabeth E. (2002). Lymphocyte apoptosis and cell replacement in human liver allografts. Transplantation, 73 (11), 1828-1834. doi: 10.1097/00007890-200206150-00022

Lymphocyte apoptosis and cell replacement in human liver allografts

2002

Conference Publication

The CCR5 delta 32 mutation is strongly associated with primary sclerosing cholangitis

Eri, RD, Jonsson, J, Pandeya, N, Purdie, D, Robinson, J, Martin, N, Powell, E, Fawcett, J and Radford-Smith, G (2002). The CCR5 delta 32 mutation is strongly associated with primary sclerosing cholangitis. PHILADELPHIA: W B SAUNDERS CO.

The CCR5 delta 32 mutation is strongly associated with primary sclerosing cholangitis

2002

Conference Publication

Intensive dietary intervention improves weight maintenance in the management of non-alcoholic fatty liver disease

Hickman, I., Powell, E., Jonsson, J. and Ash, S. (2002). Intensive dietary intervention improves weight maintenance in the management of non-alcoholic fatty liver disease. -, -, -. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(02)80922-9

Intensive dietary intervention improves weight maintenance in the management of non-alcoholic fatty liver disease

2002

Journal Article

Interaction of non-alcoholic fatty liver disease with other liver diseases

Clouston, AD and Powell, EE (2002). Interaction of non-alcoholic fatty liver disease with other liver diseases. Bailliere's Best Practice and Research in Clinical Gastroenterology, 16 (5), 767-781. doi: 10.1053/bega.2002.0329

Interaction of non-alcoholic fatty liver disease with other liver diseases

2002

Conference Publication

Weight reduction in patients with chronic HCV reduces circulating insulin levels

Hickman, Ingrid, Clouston, Andrew, Macdonald, Graeme, Ash, Susan, Prins, John, Purdie, David, Jonsson, Julie and Powell, Elizabeth (2002). Weight reduction in patients with chronic HCV reduces circulating insulin levels. -, Milan, Italy, April 18th, 2002. Ireland Ltd.: Elsevier Science. doi: 10.1016/S0168-8278(02)80921-7

Weight reduction in patients with chronic HCV reduces circulating insulin levels

2002

Conference Publication

Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels

Jonsson, J. R., Hickman, I. J., Clouston, A. D., Ash, S., Prins, J., Pandaya, N., Purdie, D. M. and Powell, E. E. (2002). Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels. 53rd Annual Meeting of the Association for the Study of Liver-Diseases (AASLD), Boston, M.A. USA, 01-05 November 2002. Hoboken, NJ United States: John Wiley and Sons.

Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels

2002

Journal Article

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C

Hickman, I. J., Clouston, A. D.., Macdonald, G. A., Purdie, D. M., Prins, J. B., Ash, S., Jonsson, J. R. and Powell, E. E. (2002). Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut, 51 (1), 89-94. doi: 10.1136/gut.51.1.89

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C

2002

Conference Publication

Fibrosis in chronic hepatitis C correlates significantly with circulating insulin levels

Hickman, Ingrid, Powell, Elizabeth, Clouston, Andrew, Ash, Susan, Pandaya, Nirmala, Purdie, David and Jonsson, Julie (2002). Fibrosis in chronic hepatitis C correlates significantly with circulating insulin levels. *, *, *. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(02)80611-0

Fibrosis in chronic hepatitis C correlates significantly with circulating insulin levels

2002

Conference Publication

Weight reduction improves biochemistry and histology in patients with chronic hepatitis C

Hickman, Ingrid, Clouston, Andrew, Ash, Susan, MacDonald, Graeme, Jonsson, Julie and Powell, Elizabeth (2002). Weight reduction improves biochemistry and histology in patients with chronic hepatitis C. Nutrition Week: A Scientific and Clinical Forum and Exposition, Bethesda, MD, 2002. Bethesda, MD: American Society for Nutrition.

Weight reduction improves biochemistry and histology in patients with chronic hepatitis C

2001

Journal Article

Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy? Authors' reply

Clouston, Andrew D., Hickman, Ingrid J., Macdonald, Graeme A., Jonsson, Julie R. and Powell, Elizabeth E. (2001). Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy? Authors' reply. Journal of Hepatology, 35 (3), 433-433. doi: 10.1016/S0168-8278(01)00116-7

Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy? Authors' reply

2001

Journal Article

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

Jonsson, Julie R., Clouston, Andrew D., Ando, Yuichi, Kelemen, Livia I., Horn, Murray J., Adamson, Michael D., Purdie, David M. and Powell, Elizabeth E. (2001). Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology, 121 (1), 148-155. doi: 10.1053/gast.2001.25480

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

2001

Journal Article

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

Clouston, Andrew D., Jonsson, Julie R., Purdie, David M., Macdonald, Graeme A., Pandeya, Nirmala, Shorthouse, Claudia and Powell, Elizabeth E. (2001). Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. Journal of Hepatology, 34 (2), 314-320. doi: 10.1016/S0168-8278(00)00096-9

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

2001

Conference Publication

Hepatitis C - host factors affecting progressive fibrosis

Clouston, A., Jonsson, J. R., Hickman, P. E. and Powell, E. (2001). Hepatitis C - host factors affecting progressive fibrosis. 6th Banff Consensus Conference on Allograft Pathology, Banff, Canada, 21-28 Apr, 2001.

Hepatitis C - host factors affecting progressive fibrosis

2001

Conference Publication

Maintenance of weight reduction after successful nutritional intervention in patients with fatty liver disease

Hickman, I., Jonsson, J. R., Clouston, A., Macdonald, G. and Powell, E. (2001). Maintenance of weight reduction after successful nutritional intervention in patients with fatty liver disease. Asia Pacific Digestive Week 2001, Sydney, Australia, 23-27 Sep, 2001. Asia: Blackwell Science.

Maintenance of weight reduction after successful nutritional intervention in patients with fatty liver disease

2001

Conference Publication

Expression of the hepatic renin angiotensin system in chronic hepatitis C

Jonsson, J. R., Clouston, A., Gochee, P. and Powell, E. (2001). Expression of the hepatic renin angiotensin system in chronic hepatitis C. AASLD 52nd Annual Meeting, Dallas, Texas, USA, 9-13 November, 2001. Philadelphia: W B Saunders.

Expression of the hepatic renin angiotensin system in chronic hepatitis C